🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,867 results for “De” Clear

  1. Salmeterol/Fluticasone Propionate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Obstructive Pulmonary Disease (COPD)

    approved small molecule active

    1 trial

  2. Salmeterol/fluticasone propionate or formoterol/budesonide

    GlaxoSmithKline

    Asthma

    approved small molecule completed

    1 trial

  3. Salofalk 1000 mg granulado de liberación prolongada, Pentasa 4 g granulado de liberación prolongada, Asacol 1600 mg comprimidos gastrorresistentes, Claversal 500 mg comprimidos gastrorresistentes, Asacol 800 mg comprimidos gastrorresistentes, PENTASA 500 mg comprimidos de liberación prolongada, Pentasa 4 g granulado de liberación prolongada, Pentasa 1g granulado de liberación prolongada, PENTASA 500 mg comprimidos de liberación prolongada, Pentasa 2g granulado de liberación prolongada, Asacol 1600 mg compri

    CERO THERAPEUTICS HOLDINGS, INC.

    Ulcerative Colitis

    approved small molecule active

    1 trial

  4. Salvianolate injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Angina

    approved small molecule active

    1 trial

  5. Same form and composition of the drug, except for the active ingredient., BRONCHO VAXOM Adulti 7 mg capsule rigide

    Fondazione Telethon ETS

    Elderly patients with a positive history of at least two respiratory system infections in the year preceding enrollment and residents for at least 6 months in a Healthcare Residence.

    approved small molecule active

    1 trial

  6. Satralizumab 120 mg

    Hoffmann-La Roche

    Neuromyelitis Optica Spectrum Disorder

    approved small molecule terminated

    1 trial

  7. Saussurea Involucrata Liquid Tonic

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postpartum Rheumatism

    approved small molecule active

    1 trial

  8. Selective serotonin reuptake inhibitor (SSRI)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anxiety Depression

    approved small molecule active

    1 trial

  9. Semaglutide

    United Therapeutics Europe Ltd

    Obesity

    approved small molecule terminated

    1 trial

  10. Semaglutide B 3.0 mg/ml PDS290

    Disc Medicine

    obesity

    approved small molecule active

    1 trial

  11. Sertraline

    United Therapeutics Europe Ltd

    Generalised Anxiety Disorder

    approved small molecule terminated

    1 trial

  12. Sertraline Hydrochloride

    The First People's Hospital of Lianyungang

    COVID-19 Vaccine Adverse Reaction

    approved small molecule completed

    1 trial

  13. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Healthy

    approved small molecule completed

    1 trial

  14. Sevelamer

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Degenerative Heart Valve Disease

    approved small molecule active

    1 trial

  15. Sevoflurane

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Middle Aged Patients

    approved small molecule completed

    1 trial

  16. Sevoflurane

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Intra-abdominal and Intrapelvic Surgery

    approved small molecule completed

    1 trial

  17. Shenfu Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Myocardial Infarction

    approved small molecule completed

    1 trial

  18. Shenfu Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Septic Cardiomyopathy

    approved small molecule active

    1 trial

  19. Shenling Baizhu granules (TCM patent medicine)

    Universal Integrated

    Low-risk Colorectal Adenoma

    approved small molecule active

    1 trial

  20. Shenlingcao Oral Liquid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carcinoma, Non-Small-Cell Lung

    approved small molecule completed

    1 trial

  21. Shexiang Baoxin pill

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease(CAD)

    approved small molecule active

    1 trial

  22. Shingrix powder and suspension for suspension for injection Herpes zoster vaccine (recombinant, adjuvanted), Shingrix powder and suspension for suspension for injection Herpes zoster vaccine (recombinant, adjuvanted)

    GlaxoSmithKline

    Herpes Zoster

    approved small molecule active

    1 trial

  23. Sildenafil citrate

    Pfizer

    Pulmonary Arterial Hypertension

    approved small molecule terminated

    1 trial

  24. Sirolimus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Antiphospholipid (aPL)-Positive

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources